logo

Last Update

This profile was last updated on 8/15/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Timothy Franson?

Timothy R. Franson

Chief Medical Officer

YourEncore Inc

HQ Phone:  (317) 226-9301

Direct Phone: (317) ***-****direct phone

Email: t***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

YourEncore Inc

20 N. Meridian Street Suite 800

Indianapolis, Indiana,46204

United States

Company Description

YourEncore's mission is to put experience to work. We offer clients the opportunity to tap into the most accomplished and experienced community of experts in the world. We offer experts the opportunity to use their experience to make a lasting difference. And ...more

Background Information

Employment History

Global Regulatory Affairs Practice

FaegreBD Consulting


President

U.S. Pharmacopeia


President

the United States Pharmacopeial Convention


Vice President of Global Regulatory Affairs

Eli Lilly and Company


Affiliations

The Villages incorporated

Board Member


Cidara Therapeutics, Inc.

Board Member


C-Path

Board Member


Food and Drug Administration

Board of Trustees


Pinoy Pharmacy Inc

Board Member


Paratek Pharmaceuticals , Inc.

Board Member


AAMC-PhRMA Clinical Trials Forum

Member


Center for Medicine in the Public Interest

Board Member


Governance Committee

Member


Food and Drug Administration

Senior Advisor


Little Red Door Cancer Agency Inc

Board Member


Infectious Diseases Society of America

Fellow


Center for Medicine in the Public Interest

Senior Fellow


CDC & NIH

Senior Advisor


Xavier University

Board of Trustees


Indiana State Museum

Board Member


American Society for Microbiology

Member


The American College

Fellow


American Federation for Clinical Research

Member


College of Pharmacy Dean's Advisory Board for Auburn University

Board Member


Parent Project Muscular Dystrophy

Advisor


Myriad Genetic Laboratories , Inc.

Board Member


Manufacturing Association

Chair of the Clinical Steering Committee


Medical College of Wisconsin

Member of the Governor's Task Force On AIDS


PhRMA companies

Committee Staff Work Group


CMR International

Member of the Regulatory Advisory Board


Pharmaceutical Research

Chair of the Clinical Steering Committee


American College of Physicians

Fellow


National Patient Safety Foundation

Board Member


industry-FDA

Committees


Education

American Board of Internal Medicine


B.S.

Pharmacy

Drake University


M.D.


M.D.

Galesburg High School


M.D. degree

University of Illinois


M.S. Chief Medical Officer


undergraduate degree

Pharmacy

University of Illinois


Web References(116 Total References)


Pino Board of Directors - pinoypharmacy.com

pinoypharmacy.com [cached]

Timothy Franson, M.D.
Director Timothy R. Franson, M.D. has served on our Board of Directors since July 2015. Since April 2014, Dr. Franson has been the Chief Medical Officer for YourEncore, a consultancy that helps global life sciences and consumer health companies accelerate new product pipelines and bring safer, more effective products to consumers. From 2009 to 2014, he was a Principal in FaegreBD Consulting's health and biosciences sector where he led the firm's global regulatory affairs practice. Until 2008, Dr. Franson was Vice President of Global Regulatory Affairs at Lilly Research Laboratories (Eli Lilly and Company). Dr. Franson has been directly involved in dozens of successful major regulatory approvals, and he has extensive clinical and regulatory experience in all pre- and post-approval phases of pharmaceutical development. He has co-chaired working groups for several industry initiatives, including the joint Food and Drug Administration, or FDA,-industry working group addressing clinical aspects of the FDA Modernization Act of 1997. Dr. Franson served as the President of the US Pharmacopeia Convention (USP), which establishes drug quality standards enforced by regulators such as FDA, from 2010 to 2015, and continues to serve on the organization's Board of Trustees as immediate Past President. In addition, Dr. Franson serves on the board of directors for Cidara Therapeutics and recently joined the board of directors for the Critical Path Institute, which collaborates with FDA and industry in innovation advances. He served on the board of directors for Myrexis (formerly Myriad) Pharmaceuticals (NASDAQ: MYRX) from 2010 to 2013. Dr. Franson received his medical degree from the University of Illinois College of Medicine.


People | Critical Path Institute

c-path.org [cached]

Timothy R. Franson, MD
Chairman Timothy R. Franson, MD Chairman Dr. Timothy R. Franson is Chief Medical Officer for YourEncore, responsible for the strategy and development of their clinical, regulatory, pharmacovigilance, and quality program offerings. He has extensive clinical and regulatory experience in all pre- and post-approval phases of pharmaceutical development relating to interactions with the FDA for policy and product issues, as well as with global regulators. He also serves as the current president of the U.S. Pharmacopeial Convention and on the Executive Committee of its Board of Trustees. Dr. Franson was the founder and president of Franson PharmAdvisors LLC, a clinical and regulatory pharmaceutical development consulting firm that merged with FaegreBD Consulting. Prior to this, Dr. Franson was Vice President of Global Regulatory Affairs at Lilly Research Laboratories (Eli Lilly and Company) after serving as their Vice President of Clinical Research and Regulatory Affairs-U.S. Dr. Franson was co-chair of the joint FDA-industry working group addressing clinical aspects of the FDA Modernization Act of 1997, including the Prescription Drug User Fee Act (PDUFA) renewal. He also co-chaired an FDA-industry safety interventions working group, was a member of the AAMC-PhRMA Clinical Trials Forum and of the Regulatory Advisory Board for the Centre for Medicines Research International. He recently served on the NIH-NCATS Treatment of Rare and Neglected Diseases (TRND) review panel, and currently serves as President of the United States Pharmacopeial Convention. Dr. Franson has authored more than 50 articles in the fields of infectious disease, epidemiology, pharmacoeconomics, and antibiotic utilization, as well as four book chapters relating to innovation policy topics. He also served as a member of the Board of Directors for Myrexis (formerly Myriad) Pharmaceuticals from 2010 to 2013. Dr. Franson received his BS in Pharmacy from Drake University, his MD from the University of Illinois College of Medicine, Internal Medicine training from the University of Iowa, and completed a Fellowship in Infectious Diseases and Epidemiology at the Medical College of Wisconsin.


Email - End Duchenne eNews - Tackling Duchenne from Every Angle - Parent Project Muscular Dystrophy

www.parentprojectmd.org [cached]

Earlier today, PPMD President Pat Furlong and Dr. Tim Franson, Chief Medical Officer of Your Encore and former VP of Global Regulatory Affairs and Drug Safety at Eli Lilly, discussed what we can expect out of the upcoming Advisory Committee meetings with the FDA.
Not only did Pat and Tim discuss the kinds of recommendations that can come out of these meetings, but they examined how these recommendations potentially affect the FDA's ultimate decision on whether or not to approve potential therapies.


FDA Guidance on Duchenne - Parent Project Muscular Dystrophy

www.parentprojectmd.org [cached]

Tim Franson, MD - FaegreBD Consulting
Dr. Timothy R. Franson is the Chief Medical Officer for YourEncore and serves as a steering committee member and advisor to PPMD. He has extensive clinical and regulatory experience in pre- and post-approval phases of pharmaceutical development relating to interactions with the FDA for policy and product issues. He also currently serves as President of the USP Convention (2010-2015). Prior to joining the YourEncore/FaegreBD Consulting team, Dr. Franson worked with Eli Lilly & Co. for more than 20 years, where he retired as Vice President of Global Regulatory Affairs & Patient Safety, led the company's U.S. Clinical Research/Trials organization, and was responsible for over 20 new drug/biologic submissions and approvals. Dr. Franson has been a leader in many industry initiatives with the FDA, including his role as co-chair of the joint FDA-industry working group addressing clinical aspects of the FDA Modernization Act of 1997, and serving on NIH-NCATS, among others. He has authored more than 50 articles in the fields of infectious disease, epidemiology, pharmacoeconomics and antibiotic utilization, as well as four book chapters relating to innovation policy topics. Tim Franson, MD - FaegreBD Consulting


Board of Directors - Paratek Pharmaceuticals

investor.paratekpharma.com [cached]

Timothy Franson, M.D.,
Director Timothy Franson, M.D., has served on our Board of Directors since July 2015. Since April 2014, Dr. Franson has been the Chief Medical Officer for YourEncore, a consultancy that helps global life sciences and consumer health companies accelerate new product pipelines and bring safer, more effective products to consumers. From 2009 to 2014, he was a Principal in FaegreBD Consulting's health and biosciences sector where he led the firm's global regulatory affairs practice. Until 2008, Dr. Franson was Vice President of Global Regulatory Affairs at Lilly Research Laboratories (Eli Lilly and Company). Dr. Franson has been directly involved in dozens of successful major regulatory approvals, and he has extensive clinical and regulatory experience in all pre- and post-approval phases of pharmaceutical development. He has co-chaired working groups for several industry initiatives, including the joint Food and Drug Administration, or FDA,-industry working group addressing clinical aspects of the FDA Modernization Act of 1997. Dr. Franson served as the President of the US Pharmacopeia Convention (USP), which establishes drug quality standards enforced by regulators such as FDA, from 2010 to 2015, and continues to serve on the organization's Board of Trustees as immediate Past President. In addition, Dr. Franson serves on the board of directors for Cidara Therapeutics and recently joined the board of directors for the Critical Path Institute, which collaborates with FDA and industry in innovation advances. He served on the board of directors for Myrexis (formerly Myriad) Pharmaceuticals (NASDAQ: MYRX) from 2010 to 2013. Dr. Franson received his medical degree from the University of Illinois College of Medicine.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory